바이오리액터 시장 규모는 2024년 167억 달러에 달할 것으로 예상되며, 2024-2035년 예측 기간 동안 11.1%의 CAGR로 확대될 것으로 예상됩니다.
바이오리액터는 정밀하게 제어된 조건에서 세포와 조직의 성장을 촉진하기 위해 업스트림 바이오 제조에 사용되는 특수 용기를 의미합니다. 이러한 조건에는 온도, pH, 압력, 통기, 영양 수준과 같은 요소가 포함되며, 살아있는 세포 및 세포 성분의 환경을 최적화하는 것을 목표로 합니다. 주요 목표는 기질에서 다양한 생물학적 제품으로의 전환을 촉진하는 것입니다. 백신, 융합 단백질, 항체, 호르몬, 인터류킨, 효소 등의 치료용 단백질부터 세포 기반 및 올리고뉴클레오티드 기반 치료제, 유전자 치료용 레트로바이러스 벡터, 신약개발 연구에 필수적인 2D 및 3D 조직구조를 모방한 첨단 in vitro 모델 등 첨단 의약품에 이르기까지 다양한 제품군을 보유하고 있습니다. 일반적으로 이러한 바이오리액터는 원통형이며 스테인리스 스틸로 제작되는 경우가 많으며, 크기는 밀리리터에서 수 리터까지 다양하며 다양한 바이오프로세스의 요구와 작동 모드에 맞게 조정됩니다.
바이오의약품에 대한 세계 수요가 급증하면서 바이오 공정 용품 시장의 성장을 크게 견인하고 있습니다. 기업들이 자체적으로 바이오의약품 생산 시설을 설립하거나 전문 기관에 위탁 생산하면서 임상 및 상업용 바이오리액터에 대한 수요가 급증하고 있습니다. 현재 추정에 따르면, 자체 생산과 외주 생산을 모두 포함하면 전 세계 바이오리액터 생산능력은 1,300만 리터를 넘어선 것으로 추산됩니다. 이러한 엄청난 수요를 바탕으로 바이오리액터 시장은 경쟁의 장으로 발전하고 있으며, 다양한 용도에 맞는 광범위한 바이오리액터 설계, 엔지니어링 및 제조에 대한 전문성을 갖춘 많은 기업들이 활발하게 활동하고 있습니다. 전통적인 스테인리스 스틸 바이오리액터부터 일회용 바이오리액터, 교반 탱크형 바이오리액터, 소규모 바이오리액터, 에어리프트 바이오리액터, 관류 바이오리액터, 버블 컬럼 바이오리액터, 광 바이오리액터에 이르기까지 다양한 제품이 제공되고 있습니다.
이 보고서는 세계 바이오리액터 시장에 대해 조사했으며, 시장 개요와 함께 제조 재료별, 바이오프로세스별, 생물학적 제제별, 지역별 동향, 시장 진입 기업 개요 등을 제공합니다.
Bioreactors Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Fabrication Material (Glass, Stainless Steel and Single use), Type of Bioprocess (Batch, Fed-batch and Continuous), Type of Biologic (Antibodies, Vaccines, Cell Therapies and Other Biologics), and Key Geographical Regions (North America, Europe, Asia-Pacific, and Rest of the World)
The Bioreactors Market is valued at USD 16.7 billion in 2024 growing at a CAGR of 11.1% during the forecast period 2024-2035.
Bioreactors represent specialized vessels employed in upstream biomanufacturing to foster the growth of cells and tissues under precisely controlled conditions. These conditions encompass factors like temperature, pH, pressure, aeration, and nutrient levels, all aimed at optimizing the environment for live cells or cellular components. The primary goal is to facilitate the conversion of substrates into a diverse array of biological products. These products span from therapeutic proteins such as vaccines, fusion proteins, antibodies, hormones, interleukins, and enzymes to cutting-edge medicinal products like cell-based and oligonucleotide-based therapies, retroviral vectors for gene therapy, and sophisticated in vitro models mimicking 2D and 3D tissue constructs, essential for drug discovery research. Typically, these bioreactors, often cylindrical and made of stainless steel, vary in size from milliliters to several liters, tailored to different bioprocessing needs and operational modes.
The surge in global demand for biopharmaceutical products has significantly propelled the growth of the bioprocessing supplies market. As companies either establish their own biopharmaceutical manufacturing facilities or opt to outsource production to specialized organizations, the demand for clinical and commercial-scale bioreactors has skyrocketed. Current estimates, including both in-house and outsourced capacities, indicate a global bioreactors capacity exceeding 13 million liters. Given this immense demand, the bioreactors market has evolved into a competitive arena, featuring numerous active companies boasting expertise in designing, engineering, and manufacturing a wide spectrum of bioreactors tailored to diverse applications. Offerings range from traditional stainless-steel bioreactors to disposable/single-use bioreactors, stirred-tank bioreactors, small-scale bioreactors, air lift bioreactors, perfusion bioreactors, bubble column bioreactors, and photobioreactors.
Key Market Segments
Fabrication Material
Stainless Steel
Single Use
Glass
Type of Bioprocess
Batch and Fed-batch
Continuous
Type of Biologic
Antibodies
Vaccines
Cell Therapies
Other Biologics
Key Geographical Regions
North America
Europe
Asia-Pacific
Rest of the World
Research Coverage:
A comprehensive analysis of the overall market landscape of companies manufacturing bioreactors, based on several relevant parameters, such as year of establishment, company size (in terms of number of employees), region of headquarters, geographical reach (North America, Europe, Asia-Pacific and Rest of the World), capacity (micro-mini, small-scale, bench-scale, lab-scale, pilot-scale and large-scale), scale of operation (preclinical, clinical and commercial), scalability, type of bioprocess (batch, fed-batch and continuous), type of cell culture (2D cell culture, 3D cell culture and 4D cell culture), mode of operation (manual, semi-automatic and automatic) and type of end user (academic institutes and research laboratories, biopharmaceutical and pharmaceutical industries, contract manufacturing organizations, and contract research organizations).
Comprehensives company competitiveness analysis of bioreactor manufacturers based on manufacturer strength (in terms of years of experience and company size), portfolio strength (considering geographical reach, number of products in portfolio, type of bioreactor, capacity, scale of operation, scalability, type of bioprocess, type of cell culture, mode of operation and end users).
Comprehensive company profiles of leading players manufacturing bioreactors (shortlisted on the basis of cumulative strength of manufacturers and product portfolio); each profile includes a brief overview of the company, along with information on its financial information (if available), product portfolio, recent developments and an informed future outlook.
A projection of the global installed capacity of bioreactors for biologics, compiled from data sourced from various publicly available industry outlets. This estimation also includes a breakdown of the available capacity categorized by fabrication material (glass, stainless steel, and single-use), cell culture source (mammalian, microbial, and others), reactor volume (less than 2,000 L, 2,000 to 5,000 L, 5,001 to 10,000 L, and over 10,000 L), manufacturer type (in-house, hybrid, and Contract Manufacturing Organizations [CMOs]), and major geographical regions (North America, Europe, Asia-Pacific, and Rest of the World).
A case study on the market landscape of bioprocess controllers and automation systems, providing information on scale of operation (laboratory, clinical, and commercial), key features (scalability / ease to use, visual data display, remote accessibility, built-in system control sensors, expansive I/O compatibility and provisions for alarms / alerts), compatibility with bioreactor system (stirred tank (glass), single use bioreactor, stirred tank (steel), rocking motion), type of bioprocess (batch, fed-batch and perfusion), and type of process controlled (cell cultivation and microbial fermentation). In addition, the chapter presents details of companies involved in the development of bioprocess control software, upstream and downstream controllers, including information on their year of establishment, company size, and location of headquarters.
A comprehensive market forecast analysis has been conducted to assess the current market size and future prospects for the bioreactors market over the coming 11 years. Utilizing multiple parameters and anticipated adoption trends, coupled with primary validations, we have developed informed estimates for market size within the forecast period spanning from 2024 to 2035. This chapter presents detailed projections of both current and future opportunities within the market, segmented across various factors including fabrication material (glass, stainless steel, and single-use), bioprocess type (batch, fed-batch, and continuous), types of biologics (such as antibodies, vaccines, cell therapies, and other biologics), and key geographical regions (North America, Europe, Asia-Pacific, and Rest of the World).
Key Benefits of Buying this Report
The report offers market leaders and newcomers valuable insights into revenue estimations for both the overall market and its sub-segments.
Stakeholders can utilize the report to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.
The report provides stakeholders with a pulse on the Bioreactors Market, furnishing them with essential information on significant market drivers, barriers, opportunities, and challenges.
Leading Market Companies
Applikon Biotechnology
Bionet
Cytiva
Eppendorf
Merck
Ollital Technology
Parr Instrument Company
Sartorius
Shanghai Bailun Biological Technology
Solaris Biotech
Solida Biotech
Zhengzhou Laboao Instrument Equipment (LABAO)